指南与共识脑血管病外科神经重症

动脉瘤性蛛网膜下腔出血术后输血指南:系统综述与现有证据批判性总结

Postoperative Transfusion Guidelines in Aneurysmal Cerebral Subarachnoid Hemorrhage: A Systematic Review and Critical Summary of Available Evidence.
指南 / 共识 · World Neurosurg · 2021-12-07

该系统综述评估了动脉瘤性蛛网膜下腔出血(SAH)成人患者围手术期红细胞输注阈值及输血相关并发症。共纳入16篇文章,发现接受输血者多为高龄、女性、WFNS IV-V级和改良Fisher 3-4级且合并症更多;输血与血管痉挛、手术部位感染、心肺并发症、住院时间延长和30天死亡率升高相关。分析显示SAH后血红蛋白目标>10 g/dL是安全的,患者可能从更高的全住院期血红蛋白最低值中获益,表现为脑血管痉挛风险降低和临床结局改善(level B class II)。

要点

  • SAH术后输血与血管痉挛、感染、心肺并发症、住院时间延长及30天死亡率升高相关。
  • SAH后血红蛋白目标>10 g/dL是安全的,患者可能从更高的全住院期血红蛋白最低值中获益。
  • 更高的血红蛋白最低值与脑血管痉挛风险降低和临床结局改善相关(level B class II)。

核心结论

  • 在SAH患者中,减少脑缺血和贫血的获益被显示超过输血相关并发症的风险。

研究设计与样本

  • 按照PRISMA指南使用PubMed、Google Scholar和Web of Science电子数据库进行系统综述,批判性评估讨论成人SAH围手术期红细胞输注阈值及输血继发并发症的原始文章,共纳入16篇文章。

主要发现

  • 接受输血的SAH患者更年长、女性、WFNS IV-V级和改良Fisher 3-4级评分,且合并高血压、糖尿病、心血管和肺部疾病等更多合并症。
  • 输血与多种术后并发症相关,包括更高的血管痉挛率、手术部位感染、心血管和呼吸系统并发症、术后住院时间延长和30天死亡率。
  • 对输血患者的分析显示,SAH后更高的血红蛋白(>10 g/dL)目标是安全的,患者可能从更高的全住院期血红蛋白最低值中获益,表现为脑血管痉挛风险降低和临床结局改善(level B class II)。

关键数值与推荐

  • SAH后血红蛋白目标>10 g/dL是安全的(level B class II)。
  • 更高的全住院期血红蛋白最低值与脑血管痉挛风险降低和临床结局改善相关(level B class II)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Surgical management of aneurysmal subarachnoid hemorrhage (SAH) often involves red blood cell (RBC) transfusion, which increases the risk of postoperative complications. RBC transfusion guidelines report on chronically critically ill patients and may not apply to patients with SAH. Our study aims to synthesize the evidence to recommend RBC transfusion thresholds among adult patients with SAH undergoing surgery. METHODS: A systematic review was conducted using PubMed, Google Scholar, and Web of Science electronic databases according to the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines to critically assess primary articles discussing RBC transfusion thresholds and describe complications secondary to RBC transfusion in adult patients with SAH in the perioperative period. RESULTS: Sixteen articles meeting our search strategy were reviewed. Patients with SAH who received blood transfusion were older, female, had World Federation of Neurosurgical Societies grade IV-V and modified Fisher grade 3-4 scores, and presented with more comorbidities such as hypertension, diabetes, and cardiovascular and pulmonary diseases. In addition, transfusion was associated with multiple postoperative complications, including higher rates of vasospasms, surgical site infections, cardiovascular and respiratory complications, increased postoperative length of stay, and 30-day mortality. Analysis of transfused patients showed that a higher hemoglobin (>10 g/dL) goal after SAH was safe and that patients may benefit from a higher whole hospital stay hemoglobin nadir, as shown by a reduction in risk of cerebral vasospasm and improvement in clinical outcomes (level B class II). CONCLUSIONS: Among patients with SAH, the benefits of reducing cerebral ischemia and anemia are shown to outweigh the risks of transfusion-related complications.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Mofor P, Oduguwa E, Tao J, et al. Postoperative Transfusion Guidelines in Aneurysmal Cerebral Subarachnoid Hemorrhage: A Systematic Review and Critical Summary of Available Evidence. World Neurosurg. 2021. PMID: 34890850. doi:10.1016/j.wneu.2021.12.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。